Top Markets
Coin of the day
Definium Therapeutics, Inc. Definium Therapeutics, Inc.

Definium Therapeutics, Inc.

DFTX
Kedudukan dalam Saham #3212
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm... Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Harga Saham
$44.42
Disegerakkan terakhir: 2026-08-25
Modal Pasaran
$5.90B
Perubahan (1 hari)
2.66%
Perubahan (1 tahun)
344.66%
Negara
US
Perdagangan Definium Therapeutics, Inc. (DFTX)

Kategori

Sejarah harga saham bagi Definium Therapeutics, Inc. (DFTX)
Harga penutupan tertinggi: $44.49 pada 2026-08-01

Harga penutupan terendah: $4.81 pada 2016-11-01
Sejarah harga saham Definium Therapeutics, Inc. dari 2016 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 65.08%
2025 74.98%
2024 107.98%
2023 34.70%
2022 -89.90%
2021 -40.72%
2020 7,946.66%
2019 -31.09%
2018 -81.58%
2017 -37.50%
2016 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.63 -12.26%
AU
$772.27 7.33%
CH